June is Myasthenia Gravis (MG) Awareness Month. This annual campaign is designed to increase public understanding of this neuromuscular autoimmune disease, support those living with it, and raise funds for research. Here at Thalocan Research Innovations. we were proud to partner with Dr. Richard Barohn, Dr. Gil Wolfe and Instructor Laura Herbelin in creating Thalocan’s…
Eric Zudak, CEO of Thalocan Research Innovations, discusses Thalocan’s role in helping to address unmet needs in the immunodermatology area. With many, if not most inflammatory skin diseases being more common in Skin of Color than in lighter pigmented skin – Thalocan is proud to provide cutting edge technology, training and tools for more accurate scientific…
Meet (most) of the Thalocan Research Innovations team at SHSA 2025 in Nashville, the 10th annual symposium on Hidradenitis Supprativa. Here at TRI we are working alongside a number of KOLs including Dr. Amit Garg and Professor John Ingram, in creating technology and training to improve clinical trials and aid in the assessment and…
We are grateful to Dr. John Ingram for his comments regarding Thalocan’s new Lesion Area Mapping Assistant. Learn more about LAMA by clicking here. In addition, Dr. Amit Garg describes how LAMA can help overcome the time-consuming hurdles encountered in lesion counting and assessment. See our discussion with Dr. Garg by clicking here.
